fadrozole has been researched along with Neoplasm Metastasis in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (85.71) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, SM; Allard, JW; Carney, W; Chinchilli, VM; Demers, L; Engle, L; Harvey, HA; Leitzel, K; Lipton, A | 1 |
| Chinchilli, VM; Demers, L; Grossberg, H; Harvey, H; Konrad, K; Leitzel, K; Lipton, A; Teramoto, Y; Volas, G | 1 |
| Bennett, P; Brünner, N; Dombernowsky, P; Herrstedt, J; Svenstrup, B; Wachmann, H | 1 |
| Cooper, J; Henderson, IC; Lipton, A; Miller, AA; Mulagha, MT; Navari, R | 1 |
| Buzdar, AU; Hortobagyi, GN; Plourde, PV | 1 |
| Falkson, CI; Falkson, HC | 1 |
| Coombes, RC; Dowsett, M; Mehta, A; Stein, RC | 1 |
6 trial(s) available for fadrozole and Neoplasm Metastasis
| Article | Year |
|---|---|
Relationship of serum HER-2/neu and serum CA 15-3 in patients with metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Breast Neoplasms; Double-Blind Method; Fadrozole; Female; Humans; Megestrol Acetate; Middle Aged; Mucin-1; Neoplasm Metastasis; Prognosis; Receptor, ErbB-2; Retrospective Studies | 2002 |
Elevated serum c-erbB-2 antigen levels and decreased response to hormone therapy of breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antigens; Breast Neoplasms; Chi-Square Distribution; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Fadrozole; Female; Gene Amplification; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Regression Analysis; Survival Analysis; Tamoxifen; Treatment Outcome | 1995 |
Sex hormone levels in postmenopausal women with advanced metastatic breast cancer treated with CGS 169 49A.
Topics: Aged; Androgens; Breast Neoplasms; Dose-Response Relationship, Drug; Estrogens; Fadrozole; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Postmenopause; Sex Hormone-Binding Globulin; Time Factors | 1994 |
Fadrozole hydrochloride in postmenopausal patients with metastatic breast carcinoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Dose-Response Relationship, Drug; Estrogen Antagonists; Fadrozole; Female; Humans; Middle Aged; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Postmenopause; Prospective Studies | 1996 |
A randomised study of CGS 16949A (fadrozole) versus tamoxifen in previously untreated postmenopausal patients with metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Breast Neoplasms; Confidence Intervals; Disease-Free Survival; Enzyme Inhibitors; Fadrozole; Female; Humans; Middle Aged; Neoplasm Metastasis; Postmenopause; Prognosis; Prospective Studies; Survival Rate; Tamoxifen | 1996 |
Potency and selectivity of the non-steroidal aromatase inhibitor CGS 16949A in postmenopausal breast cancer patients.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Estrogens; Estrone; Fadrozole; Female; Gonadal Steroid Hormones; Humans; Imidazoles; Menopause; Middle Aged; Neoplasm Metastasis; Nitriles; Randomized Controlled Trials as Topic | 1990 |
1 other study(ies) available for fadrozole and Neoplasm Metastasis
| Article | Year |
|---|---|
Aromatase inhibitors in metastatic breast cancer.
Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Fadrozole; Female; Humans; Megestrol Acetate; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Nitriles; Tamoxifen; Triazoles | 1996 |